News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,396 Results
Type
Article (79236)
Company Profile (647)
Press Release (753511)
Multimedia
Podcasts (137)
Webinars (17)
Section
Business (230167)
Career Advice (3961)
Deals (39453)
Drug Delivery (129)
Drug Development (89882)
Employer Resources (198)
FDA (17972)
Job Trends (17206)
News (391784)
Policy (39228)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (102)
Alliances (56521)
ALS (112)
Alzheimer's disease (1534)
Antibody-drug conjugate (ADC) (184)
Approvals (17920)
Artificial intelligence (343)
Autoimmune disease (33)
Automation (18)
Bankruptcy (403)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (441)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (372)
Cancer (2884)
Cardiovascular disease (232)
Career advice (3384)
Career pathing (34)
CAR-T (200)
CDC (34)
Cell therapy (546)
Cervical cancer (23)
Clinical research (73099)
Collaboration (1035)
Company closure (3)
Compensation (649)
Complete response letters (30)
COVID-19 (2893)
CRISPR (64)
C-suite (315)
Cystic fibrosis (117)
Data (2855)
Decentralized trials (2)
Denatured (47)
Depression (65)
Diabetes (329)
Diagnostics (6952)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (148)
Drug pricing (146)
Drug shortages (35)
Duchenne muscular dystrophy (122)
Earnings (96087)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (130577)
Executive appointments (878)
FDA (19560)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (930)
Gene editing (141)
Generative AI (31)
Gene therapy (413)
GLP-1 (895)
Government (5203)
Grass and pollen (6)
Guidances (179)
Healthcare (20901)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (170)
Immuno-oncology (8)
Indications (36)
Infectious disease (3067)
Inflammatory bowel disease (162)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (114)
Interviews (778)
IPO (17839)
IRA (53)
Job creations (5044)
Job search strategy (2744)
Kidney cancer (15)
Labor market (53)
Layoffs (581)
Leadership (25)
Legal (10038)
Liver cancer (83)
Lung cancer (412)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (402)
MASH (92)
Medical device (14675)
Medtech (14680)
Mergers & acquisitions (22282)
Metabolic disorders (878)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (134)
Neuropsychiatric disorders (38)
Neuroscience (2239)
NextGen: Class of 2025 (7658)
Non-profit (5087)
Now hiring (46)
Obesity (465)
Opinion (285)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (111)
Parkinson's disease (188)
Partnered (23)
Patents (293)
Patient recruitment (142)
Peanut (53)
People (64890)
Pharmaceutical (134)
Pharmacy benefit managers (24)
Phase I (22598)
Phase II (31838)
Phase III (23989)
Pipeline (1599)
Policy (215)
Postmarket research (3348)
Preclinical (10071)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (276)
Rare diseases (492)
Real estate (7244)
Recruiting (75)
Regulatory (26541)
Reports (61)
Research institute (2661)
Resumes & cover letters (627)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (91)
Series A (159)
Series B (105)
Service/supplier (27)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (36)
Startups (4271)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (63)
The Weekly (88)
Vaccines (874)
Venture capitalists (51)
Weight loss (316)
Women's health (45)
Worklife (20)
Date
Today (150)
Last 7 days (555)
Last 30 days (2617)
Last 365 days (34399)
2025 (16192)
2024 (37936)
2023 (42567)
2022 (53928)
2021 (58723)
2020 (57665)
2019 (51323)
2018 (39108)
2017 (37002)
2016 (38037)
2015 (44094)
2014 (38982)
2013 (35311)
2012 (37265)
2011 (37285)
2010 (37199)
Location
Africa (1229)
Alabama (66)
Alaska (7)
Arizona (263)
Arkansas (14)
Asia (49379)
Australia (8505)
California (7433)
Canada (2300)
China (676)
Colorado (319)
Connecticut (334)
Delaware (191)
Europe (112607)
Florida (1100)
Georgia (253)
Hawaii (1)
Idaho (65)
Illinois (696)
India (31)
Indiana (370)
Iowa (18)
Japan (218)
Kansas (114)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1066)
Massachusetts (5679)
Michigan (265)
Minnesota (461)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (72)
New Jersey (2077)
New Mexico (31)
New York (2086)
North Carolina (1203)
North Dakota (10)
Northern California (3211)
Ohio (243)
Oklahoma (16)
Oregon (46)
Pennsylvania (1589)
Puerto Rico (17)
Rhode Island (39)
South America (1609)
South Carolina (34)
South Dakota (1)
Southern California (2741)
Tennessee (121)
Texas (1107)
United States (28042)
Utah (221)
Virginia (197)
Washington D.C. (79)
Washington State (655)
West Virginia (4)
Wisconsin (80)
833,396 Results for "biotronik se and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KGKARL STORZ to provide up to $20 million in bridge financing
Asensus Surgical, Inc. announced that it has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company to engage in diligence and negotiations regarding the terms of a potential transaction whereby KARL STORZ may acquire Asensus.
April 3, 2024
·
9 min read
Press Releases
Eurofins Scientific SE: Director/PDMR Shareholding
May 15, 2025
·
2 min read
Press Releases
Merck’s Investigational Zilovertamab Vedotin at 1.75 mg/kg Dose Plus Standard of Care Showed Promising Antitumor Activity, Including Complete Response Rate, in Patients With Relapsed/Refractory DLBCL in Phase 2 Portion of waveLINE-003 Trial
May 30, 2025
·
10 min read
Press Releases
BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen
June 2, 2025
·
7 min read
Press Releases
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025
April 29, 2025
·
3 min read
Press Releases
PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update
May 29, 2025
·
7 min read
Press Releases
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
April 10, 2025
·
3 min read
Press Releases
CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE
May 15, 2025
·
6 min read
Press Releases
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
May 6, 2025
·
5 min read
Press Releases
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results
April 17, 2025
·
7 min read
1 of 83,340
Next
